Stock Comparison
MRNA vs VRTX
Moderna Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$26.69B
$124.70B
P/E (TTM)
—
29.2
Forward P/E
23.0
25.8
Price/Sales
12.0
10.2
Price/Book
3.2
6.4
EV/EBITDA
4.6
24.0
Dividend Yield
—
—
Profitability
Net Margin
-143.50%
35.50%
Operating Margin
-131.10%
38.10%
Return on Equity
-36.60%
24.20%
Return on Assets
-13.10%
12.10%
Growth (YoY)
Revenue Growth
260.20%
7.80%
Earnings Growth
-85.10%
61.40%
Price & Risk
Beta
1.0
0.3
52-Week High
$69.28
$507.92
52-Week Low
$22.28
$362.50
Analyst Target
$43.45
$548.69
Compare MRNA and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.